Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease.
Caffeine has been considered a neuroprotective agent against Parkinson's disease (PD). Recent metabolomic analysis showed that levels of caffeine and its metabolites were decreased in sera from patients with PD compared with those from healthy controls. We focused on theophylline, which is one...
Main Authors: | Takuma Ohmichi, Takashi Kasai, Tadashi Kosaka, Keisuke Shikata, Harutsugu Tatebe, Ryotaro Ishii, Makiko Shinomoto, Toshiki Mizuno, Takahiko Tokuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6059449?pdf=render |
Similar Items
-
Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
by: Makiko Shinomoto, et al.
Published: (2021-01-01) -
Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy.
by: Takashi Kasai, et al.
Published: (2016-01-01) -
Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients.
by: Makiko Shinomoto, et al.
Published: (2019-01-01) -
Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
by: Takuma Ohmichi, et al.
Published: (2020-12-01) -
Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference.
by: Ryotaro Ishii, et al.
Published: (2015-01-01)